FDA Extends Dupilumab COPD Decision to September 2024
The FDA moved the target date for their decision on the dupilumab application by 3 months, citing a need for more efficacy data from its pivotal phase 3 trials.
Source: hcplive.com
Published February News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Published February. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Published February Today - Breaking & Trending Today
Glomerulonephritis Patients Face High Risk of Recurrence After Kidney Transplant
A single-center assessment showed patients with glomerulonephritis may face a heightened risk of primary disease recurrence up to 1 year after transplant.
Source: hcplive.com
Insurance Coverage Limits JAKi Therapy Access for Patients With AA, Especially Non-White Populations
A survey study showed major barriers to Janus kinase inhibitor (JAKi) therapy for patients with alopecia areata, especially for non-White patients who face higher rates of being uninsured and struggle more to afford the treatment.
Source: ajmc.com
Black and Native Americans Overwhelmed by "Deaths of Despair," UCLA Health Study Finds
Contrary to previous assumptions, the analysis found that mortality rates from deaths of despair among middle-aged Black Americans exceeded those of their White counterparts in 2022.
Source: ajmc.com
Little Pills, Big Risks: The Untold Dangers of Referring to Low-Dose Aspirin as 'Baby Aspirin'
Aspirin, known as acetylsalicylic acid, has been marketed in ways that have de-emphasized potential risks to children.
Source: pharmacytimes.com